Peterson Thomas III 4
4 · Evolent Health, Inc. · Filed Mar 5, 2019
Insider Transaction Report
Form 4
Peterson Thomas III
Chief Operating Officer
Transactions
- Award
Leveraged Restricted Stock Unit
2019-03-01+85,594→ 85,594 totalExercise: $0.00→ Class A Common Stock (85,594 underlying)
Footnotes (3)
- [F1]Each leveraged stock unit ("LSU") represents the contingent right to receive, upon vesting, between 0% and 200% of one share of the Issuer's Class A common stock, subject to the level of achievement of applicable performance conditions. The resulting number of shares acquired upon vesting of the LSUs, if any, is based on the cumulative performance of the Issuer's Class A common stock.
- [F2]These LSUs vest on March 2, 2022
- [F3]These LSUs do not expire